Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: A randomised controlled trial

British Journal of General Practice

Volumn 56, Issue 527, 2006, Pages 437-443

  Walker, Ann F ^a   Marakis, Georgios ^a   Simpson, Eleanor ^b   Hope, Jessica L ^a   Robinson, Paul A ^b   Hassanein, Mohamed ^c   Simpson, Hugh C R ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^c GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

Complementary therapies; Crataegus; Herb drug interactions; Hypertension; Phytotherapy; Plant extracts

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CRATAEGUS EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLICLAZIDE; INSULIN; METFORMIN; PLACEBO; TRACE ELEMENT;

ADULT; ARTICLE; BERRY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRATAEGUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FAT INTAKE; FEMALE; FLOWER; FOOD INTAKE; GENERAL PRACTICE; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PLANT LEAF; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUGAR INTAKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; WELLBEING;

AGED; ANTIHYPERTENSIVE AGENTS; CRATAEGUS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HERB-DRUG INTERACTIONS; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 33745156121     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mills S, Bone K. Principles and practice of phytotherapy: modern herbal medicine. Edinburgh: Churchill Livingstone, 2000.
2. British Herbal Medicine Association. A guide to traditional herbal medicines: a sourcebook of accepted traditional uses of medicinal plants within Europe. Bournemouth: BHMA, 2003.
3. Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003; 114(8): 665-674.
4. British Heart Foundation. Herbs and the heart. Factfile 09/2003. London: BHF, 2003.
5. Yao LH, Jiang YM, Shi J, et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004; 59(3): 113-122.
6. Mills S, Bone K. The essential guide to herbal safety. Edinburgh: Churchill Livingstone, 2005.
7. Tankanow R, Tamer HR, Streetman DS, et al. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 2003; 43(6): 637-642.
8. Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother Res 2002; 16(1): 48-54.
9. Pocock SJ. Clinical trials: a practical approach. Chichester: John Wiley & Sons, 1983.
10. Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994; 11(5): 510-516.
11. Department of Health. Report on health and social subjects No 46. Nutritional aspects of cardiovascular disease. London: HMSO, 1994.
12. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda MD: National Institutes of Health; National Heart, Lung, and Blood Institute, 1998.
13. Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness - a critical review. Int J Obes Relat Metab Disord 1998: 22(8): 719-727.
14. Connor H, Annan F, Bunn E, et al. The implementation of nutritional advice for people with diabetes. Diabet Med 2003; 20(10): 786-807.
15. Cappuccio FP, Elliott P, Allender PS, et al. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol 1995; 142(9): 935-945.
16. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354(9195): 2048-2049.
17. Witteman JC, Grobbee DE, Derkx FH, et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60(1): 129-135.
18. Mangoni AA, Sherwood RA, Swift CG, et al. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002; 252(6): 497-503.
19. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66(6): 2454-2466.
20. Resnick LM, Barbagallo M, Dominguez LJ, et al. Relation of cellular potassium to other mineral ions in hypertension and diabetes. Hypertension 2001; 38(3 Pt 2): 709-712.
21. Mihailovic MB, Avramovic DM, Jovanovic IB, et al. Blood and plasma selenium levels and GSH-Px activities in patients with arterial hypertension and chronic heart disease. J Environ Pathol Toxicol Oncol 1998; 17(3-4): 285-289.
22. Department of Health. Report of health and social subjects No. 41. Dietary reference values for food energy and nutrients for the United Kingdom. London: HMSO, 1991.
23. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr 1987; 45(2): 469-475.
24. Conlin PR, Chow D, Miller ER III, et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 2000; 13(9): 949-955.
25. Farvid MS, Jalali M, Siassi F, et al. The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr 2004; 23(3): 272-279.
26. Bonnefont-Rousselot D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat Endocrinol 2004; 3(1): 41-52.
27. Barringer TA, Kirk JK, Santaniello AC, et al. Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003; 138(5): 365-371.
28. Schmidt U, Kuhn U, Ploch M, et al. Efficacy of the hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. Phytomedicine 1994; 1(1): 17-24.